Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Abbott Laboratories buy The Goldman Sachs Group, Inc.

Abbott Laboratories
Start price
€133.42
04.03.25 / 50%
Target price
€146.25
04.03.26
Performance (%)
-22.53%
Price
€103.36
21.01.26
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -22.53%. This prediction currently runs until 04.03.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Abbott Laboratories -3.744% -3.744%
iShares Core DAX® -1.933% 2.239%
iShares Nasdaq 100 -0.972% 0.226%
iShares Nikkei 225® -2.056% 5.685%
iShares S&P 500 -1.185% 0.867%

Comments by The_Goldman_Sachs_Gr for this prediction

In the thread Discuss Abbott Laboratories
Prediction Buy
Perf. (%) -22.53%
Target price 146.254
Change
Ends at 04.03.26

Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $138.00 to $154.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat

The Goldman Sachs Group, Inc. 
0
Report Share
04.03.25

Stopped prediction by The_Goldman_Sachs_Gr for Abbott Laboratories

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€106.22
15.01.26
€130.60
15.01.27
-2.88%
21.01.26

The Goldman Sachs Group, Inc. 
15.01.26 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€115.08
01.10.25
€133.73
01.10.26
-10.18%
21.01.26

The Goldman Sachs Group, Inc. 
01.10.25 50%